SynthesisDiabetes care2022

SGLT2 Inhibition, Choline Metabolites, and Cardiometabolic Diseases: A Mediation Mendelian Randomization Study.

Min Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.